Acute myelogenous leukemia following treatment of invasive cervix carcinoma: a case report and a review of the literature.
Second malignancy is one of the late complications of long-term cancer survivors, treated with radiation or chemotherapy. Here is a case report on acute myelogenous leukemia, which developed after 63 months following the completion of treatment with surgery and platinum-based chemoradiation in a patient of carcinoma cervix IB. The above-mentioned second malignancy is one of the late sequelae of platinum-based chemoradiation. This case is reported here for documentation because of its rarity.
Samanta
Dipti R
DR
Division of Radiation Oncology, Medical Oncology, and Oncopathology, A. H. Regional Cancer Centre, Cuttack, Orissa, India.
Senapati
Surendra N
SN
Sharma
Praveen K
PK
Mohanty
Asit
A
Samantaray
Sagarika
S
D000970:Antineoplastic Agents / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D002945:Cisplatin / Q000009:adverse effects; D005260:Female; D006801:Humans; D007044:Hysterectomy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D008207:Lymphatic Metastasis / Q000473:pathology; D008875:Middle Aged; D009367:Neoplasm Staging; D016609:Neoplasms, Second Primary / Q000188:drug therapy / Q000473:pathology*; D011878:Radiotherapy / Q000009:adverse effects; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*
D000970:Antineoplastic Agents; D002945:Cisplatin